Pharmaceutical case processing is witnessing a 15% annual increase in adverse event reports, according to FDA statistics. Over the last decade the industry has exhausted resourcing to low-cost ...

Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral ...

When referring to this article, please cite it as Hennessy, M. How Innovation and Risk Management Are Reshaping Modern Drug ...

PROMIS Centre, a research centre focused on the development of methods for analysis and optimisation of pharmaceutical processes, has built a new and unique continuous processing pharmaceutical ...

The pharmaceutical contract manufacturing market is experiencing strong growth, primarily driven by the rising prevalence of chronic and infectious diseases. The increasing demand for biologics and ...

Evolving industry demands are driving the need for greater flexibility and innovation in processing equipment for pharmaceutical manufacturing. Flexibility in pharmaceutical manufacturing is becoming ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Digital twins — a digital replica of the factory floor — are an important ...

TORONTO, Dec. 2, 2025 /CNW/ -- Katalyze AI today announced the appointment of Hannes Bretschneider as Chief AI Officer. Hannes will lead the development of Agentic AI architecture and expand the ...

The Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to reach a value of USD 2196 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 12.95% ...